Effect of early invasive treatment in elderly patients with high-risk heart conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to compare major adverse cardiovascular events (MACE) and their predisposing factors in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome who receive either early or late invasive treatment. It seeks to answer two key questions: the factors associated with a late invasive strategy and whether there is a significant difference in mortality and complication rates between the two treatment groups after 12 months. The study will involve patients aged 60 and older who meet specific criteria for high-risk conditions and receive reperfusion intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* aged 60 years and older
* high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards).
* receives reperfusion intervention.

Exclusion Criteria:

* Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion.
* Incomplete medical records.

Where it's running

• Gia Dinh people hospital
  Ho Chi Minh City, Vietnam Recruiting

Study contacts

• Study coordinator: Sang Thanh Nguyen, Doctor
• Email: drsangthanhnguyen@gmail.com
• Phone: +84902489252

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care

  This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07913152

• Digital cardiac rehab to help heart attack patients improve function

  A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.

  Recruiting Cairo University · Minya, Minya Province · NCT07867197

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Innate Immune Cells and Early Fibrotic Repair After a Heart Attack

  This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.

  Recruiting Shanghai 10th People's Hospital · Shanghai · NCT07764588

• Remote Balance in Everyday Life for young MI patients with distress

  This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.

  Recruiting Uppsala University · Uppsala · NCT07706816

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.